Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Rollover Protocol to Provide Subjects Completing the FTC-203 Study in South Africa With Continued Access to Emtricitabine

NCT00743340 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT00743340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00743340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Rollover Protocol to Provide Subjects Completing the FTC-203 Study in South Africa With Continued Access to Emtricitabine
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
November 22, 2005
Completion date
February 13, 2017
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection